Celularity (CELUW) Free Cash Flow (2019 - 2025)
Celularity (CELUW) reported Free Cash Flow of -$5.1 million for Q4 2025, down 439.52% year-over-year from $1.5 million in Q4 2024, and down 22.7% quarter-over-quarter from -$4.2 million in Q3 2025.
Celularity (CELUW) Free Cash Flow (2019 - 2025) Analysis & Trends
Celularity (CELUW) has 7 years of Free Cash Flow data on file, last reported at -$5.1 million in Q4 2025.
- Free Cash Flow for Q4 2025 came in at -$5.1 million, down 439.52% year-over-year; the trailing twelve-month figure through Dec 2025 was -$13.3 million (down 101.98% YoY), and the FY2025 annual result was -$13.3 million, down 101.98% from the prior year.
- Free Cash Flow declined to -$5.1 million in Q4 2025 per CELUW's latest filing, from -$4.2 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $1.5 million in Q4 2024 and troughed at -$39.3 million in Q3 2022.
- A 5-year average of -$15.7 million and a median of -$9.9 million in 2023 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2021 and 2024: Free Cash Flow plunged 9123.24% in 2021, then surged 132.41% in 2024.
- A 5-year view of Free Cash Flow shows it stood at -$36.6 million in 2021, then rose by 29.57% to -$25.8 million in 2022, then jumped by 82.03% to -$4.6 million in 2023, then jumped by 132.41% to $1.5 million in 2024, then slumped by 439.52% to -$5.1 million in 2025.
- Business Quant data shows CELUW's Free Cash Flow at -$5.1 million in Q4 2025, -$4.2 million in Q3 2025, and -$999000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Celularity | - | - | -3.27 Mn | -5.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.10 Mn |
| Dec 31, 2025 | -5.10 Mn |
| Sep 30, 2025 | -4.16 Mn |
| Sep 30, 2025 | -4.16 Mn |
| Jun 30, 2025 | -999,000.00 |
| Jun 30, 2025 | -999,000.00 |
| Mar 31, 2025 | -2.99 Mn |
| Mar 31, 2025 | -2.99 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | -144,000.00 |
| Sep 30, 2024 | -144,000.00 |
| Jun 30, 2024 | -3.51 Mn |
| Jun 30, 2024 | -3.51 Mn |
| Mar 31, 2024 | -4.41 Mn |
| Mar 31, 2024 | -4.41 Mn |
| Dec 31, 2023 | -4.64 Mn |
| Dec 31, 2023 | -4.64 Mn |
| Sep 30, 2023 | -8.83 Mn |
| Sep 30, 2023 | -8.83 Mn |